Postoperative Narcotic Use After Laparoscopic Gynecologic Surgery
Status:
Withdrawn
Trial end date:
2020-07-30
Target enrollment:
Participant gender:
Summary
This will be a prospective, randomized, double blinded placebo-controlled study at Erlanger
hospital. Eligible patients who provide consent will be randomized into one of two arms
receiving continuous intra-peritoneal local anesthetic with 0.2% Ropivacaine or saline.
Phase:
N/A
Details
Lead Sponsor:
Camille Ladanyi MD University of Tennessee, Chattanooga